Discontinued — last reported Q4 '24
Over 2 years (FY 2021 to FY 2024), Diagnostics — Goodwill, Acquired During Period shows a downward trend with a -100.0% CAGR.
An increase shows active inorganic growth, while zero indicates a focus on organic growth or a pause in M&A.
The value of goodwill recognized specifically from acquisitions completed within the current reporting period for the di...
Standard disclosure for companies with active acquisition pipelines.
dhr_segment_diagnostics_goodwill_acquired_during_period| Q2 '21 | Q3 '21 | Q4 '21 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $27.50M | $27.50M | $27.50M | $13.00M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | +0.0% | +0.0% | -52.7% | -100.0% | — | — | — | — | — | — | — |
| YoY Change | — | — | — | -52.7% | — | — | — | -100.0% | — | — | — | — |